Erica Jordan

Insider Reports History

Entity
Individual
Location
1222 Demonbreun Street, Suite 2000, Nashville, TN
Signature
/s/ Dwight Moxie, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erica Jordan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Revance Therapeutics, Inc. Chief Commercial Officer Common Stock 115K $437K $3.80 Apr 16, 2024 Direct

Insider Reports Filed by Erica Jordan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RVNC Revance Therapeutics, Inc. Apr 16, 2024 1 -$9.1K 4 Apr 17, 2024 Chief Commercial Officer
RVNC Revance Therapeutics, Inc. Feb 27, 2024 0 $0 3 Feb 29, 2024 Chief Commercial Officer